Skip to main content

Table 3 Differentially expressed genes in the ACL-X knee by region in the tibial plateau

From: Site-specific analysis of gene expression in early osteoarthritis using the Pond-Nuki model in dogs

p value

ACL-X

Control

CrMTP

CrLTP

ACL-X

Control

p value

<0.05

0.093 ± 0.02

0.018 ± 0.018

MMP 13

COL 1

5.46 ± 3.96

0.48 ± 0.08

<0.05

    

COL 2

1022 ± 651

254 ± 84

<0.05

    

MMP 13

0.147 ± 0.012

0 ± 0

<0.05

    

INOS

0.362 ± 0.065

0.04 ± 0.04

<0.05

    

COX-2

0.007 ± 0.005

0 ± 0

<0.05

    

TIMP-1

35.3 ± 4.6

8.4 ± 5.4

<0.05

    

MMP 3

2.428 ± 1.272

0.587 ± 0.18

<0.05

    

ADAMTS 5

0.132 ± 0.05

0.024 ± 0.024

<0.05

p value

ACL-X

Control

CaMTP

CaLTP

ACL-X

Control

p value

<0.05

378.6 ± 321.42

9.05 ± 7.08

COL 1

COL 1

78.85 ± 43.79

1.98 ± 1.72

<0.05

<0.05

2787 ± 1919

594 ± 151

COL 2

COL 2

1926 ± 939

708 ± 49

<0.05

<0.05

0.074 ± 0.059

0.007 ± 0.007

MMP 13

MMP 13

0.05 ± 0.002

0.011 ± 0.011

<0.05

<0.05

0.051 ± 0.044

0.003 ± 0.001

COX-2

COX-2

0.019 ± 0.006

0.002 ± 0.002

<0.05

<0.05

0.189 ± 0.019

0.088 ± 0.002

INOS

    

<0.05

0.023 ± 0.011

0.002 ± 0.002

ADAMTS 5

    

<0.05

1.4 ± 0.07

3.71 ± 0.08

TIMP-2

TIMP-2

0.99 ± 0.02

2.7 ± 0.8

<0.05

  1. Differentially expressed genes in the ACL-transected knee by region in the tibial plateau compared to the contralateral normal control. All genes listed were up regulated in the ACL-transected stifle except TIMP-2, which was down regulated in the ACL-transected stifle. Values listed are the mean relative level of expression (± standard error) for each gene compared to the house keeping gene GAPDH. Significant differences were determined using REST-XL, and relative expression levels were determined using Q-Gene.